OMBCL Unplugged: When The Words “Chronic” & “Cured” Aren’t So Simple
MBC Patients, Living with MBC, Diagnosis and Treatment, Difficult Life Choices, Medical Community Our MBClife MBC Patients, Living with MBC, Diagnosis and Treatment, Difficult Life Choices, Medical Community Our MBClife

OMBCL Unplugged: When The Words “Chronic” & “Cured” Aren’t So Simple

Welcome to our first "Our MBC Life Unplugged" episode, where we wrap up the fall season with an honest, unscripted conversation. What happens when someone is told they might actually be cured? It’s what we all dream of hearing, but when we started talking, it opened a Pandora’s box of questions and concerns:

Is a cure really possible?
Should I go off treatment?
What if the doctor is wrong and my cancer comes back?

This episode dives deep into these complexities and more. So, grab your favorite beverage and join us for a raw, heartfelt discussion you won’t want to miss.



Read More
Road to a Cure - ABC with Dr. Fatima Cardoso
Novel Treatments, Medical Community, BC Policies and Legislation, Clinical Trials Process, Health Disparities, Diagnosis and Treatment, Entities of Cancer, Precision Oncology, MBC Imaging and Profiling, Difficult to Treat, Obstacles to Better Outcomes, Clinical Research, Basic Science, Translational Research Our MBClife Novel Treatments, Medical Community, BC Policies and Legislation, Clinical Trials Process, Health Disparities, Diagnosis and Treatment, Entities of Cancer, Precision Oncology, MBC Imaging and Profiling, Difficult to Treat, Obstacles to Better Outcomes, Clinical Research, Basic Science, Translational Research Our MBClife

Road to a Cure - ABC with Dr. Fatima Cardoso

This is the sixth stop in our series Road to a Cure. From the start our goal for this series was not only to educate and give hope to every listener but also to ensure that each of these special interviews feels like an intimate conversation with our smartest friend who also happens to be an oncologist researcher. This episode will not disappoint., Co-hosts Victoria Goldberg and Lisa Laudico, sit down with the Director of the Breast Unit of the Champalimaud Clinical Center in Lisbon, Portugal, Dr. Fatima Cardoso.

Read More
Road to a Cure - ADC & SARM
Novel Treatments, Medical Community, Challenges and Barriers, Health Disparities, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Immunotherapy, Difficult to Treat, Clinical Research, Long Term Adverse Effects Our MBClife Novel Treatments, Medical Community, Challenges and Barriers, Health Disparities, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Immunotherapy, Difficult to Treat, Clinical Research, Long Term Adverse Effects Our MBClife

Road to a Cure - ADC & SARM

How famous is Dr Hope Rugo? She belongs to a tiny elite group of oncologists who have their own Wikipedia page. Dr. Dennis Slamon is quite possibly the only other member. Enough said. No surprise that we can’t wait to hear what she has to say about a new class of drugs, known as ADCs and specifically, the first ADC for mTNBC that already has a nickname – Sassy (sacituzumab govitecan). Do you know what a SARM is? It is a special class of drugs for those who are Androgen Receptor (AR) positive. Listen and find out.

Read More
Road to a Cure - use of immunotherapy
Immunotherapy, MBC Stories, Patient Advocates, Novel Treatments, Medical Community, Challenges and Barriers, Clinical Trials Process, Difficult to Treat, Obstacles to Better Outcomes, Entities of Cancer, MBC Imaging and Profiling Our MBClife Immunotherapy, MBC Stories, Patient Advocates, Novel Treatments, Medical Community, Challenges and Barriers, Clinical Trials Process, Difficult to Treat, Obstacles to Better Outcomes, Entities of Cancer, MBC Imaging and Profiling Our MBClife

Road to a Cure - use of immunotherapy

This week we are visiting Dr Stephanie Goff at the NIH in Bethesda, Maryland. Dr Goff is a surgical oncologist and a senior member of a research team led by Dr. Steven A. Rosenberg, a man widely regarded as the father of immunotherapy. A friend, who knows a thing or two about this place. is joining us on this trip. Her name is Judy Perkins, and she is the first MBC patient who has been cured by a revolutionary immunotherapy treatment, known as adoptive cell therapy, that was administered by Dr Goff and her colleagues at the NCI.

Read More
Road to a Cure - Dr. Heather Parsons & Dr. Nancy Lin
Novel Treatments, Medical Community, Challenges and Barriers, MBC Research Funding, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat, Obstacles to Better Outcomes, Patient Reported Outcomes and Out of the Box Treatment Options, Clinical Research Our MBClife Novel Treatments, Medical Community, Challenges and Barriers, MBC Research Funding, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat, Obstacles to Better Outcomes, Patient Reported Outcomes and Out of the Box Treatment Options, Clinical Research Our MBClife

Road to a Cure - Dr. Heather Parsons & Dr. Nancy Lin

The Road to a Cure series heads to Boston to have Senior Producer and Co-host, Victoria Goldberg and co-host Dr. Paula Jayne speak with Dr. Nancy Lin and Dr. Heather Parsons about the possibilities and the current barriers to considering a cure for HER2+ MBC. Dr. Parsons and Dr. Lin are medical oncologists and professors at Harvard Medical School. Dr. Lin is also the Director of the Metastatic Breast Cancer Program and the Associate Chief of the Division of Breast Oncology at Dana Farber Cancer Institute. While an amazing gift, long-term survival among some HER2+ patients can also sometimes bring special challenges. Given the higher prevalence of brain metastases among HER2+ patients, Drs. Lin and Parsons also discuss current research on brain mets, along with areas of promising overall MBC research for each subtype.

Read More
Road to a Cure - Dr. Sara Hurvitz
Novel Treatments, Medical Community, Challenges and Barriers, Clinical Research, Obstacles to Better Outcomes, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat Our MBClife Novel Treatments, Medical Community, Challenges and Barriers, Clinical Research, Obstacles to Better Outcomes, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat Our MBClife

Road to a Cure - Dr. Sara Hurvitz

The Road to a Cure series gets on the redeye to LA to have Senior Producer and Co-host, Victoria Goldberg and co-host Kate Pfitzer speak with Dr. Sara Hurvitz. She talks about her perspective on where we are as we work for a cure, the HER2+ studies she is excited about, and other research that is intriguing as it relates to all subtypes

Read More
Road to a Cure - Dr. Larry Norton
Novel Treatments, Medical Community, Challenges and Barriers, AI and Big Data, Diagnosis and Treatment, MBC Imaging and Profiling, Obstacles to Better Outcomes Our MBClife Novel Treatments, Medical Community, Challenges and Barriers, AI and Big Data, Diagnosis and Treatment, MBC Imaging and Profiling, Obstacles to Better Outcomes Our MBClife

Road to a Cure - Dr. Larry Norton

Our special series, Road to a Cure, makes its first stop at Memorial Sloan Kettering Cancer Center in New York, with an interview with Dr. Larry Norton. He is Senior Vice President in the Office of the President, and Deputy Director for Clinical and Translational Science in the Memorial Sloan Kettering Cancer Center. Dr. Norton’s also the Medical Director of the Evelyn H. Lauder Breast Center at MSK and a founder of the Breast Cancer Research Foundation. Senior Producer & Host Lisa Laudico and co-host Dr. Ellen Landsberger speak with Dr. Norton on what he sees happening with Metastatic Breast Cancer research today. They ask him about what lines of research are most exciting to him and also all about how he cares for his own mental health

Read More